Can ferritin be elevated as an acute-phase reactant while transferrin saturation is low in inflammation-related anemia?

Ferritin functions as a critical positive acute-phase reactant, and its elevation is a hallmark of the body's systemic response to various physiological stressors. In clinical practice, interpreting ferritin levels requires distinguishing between true iron overload and reactive elevations triggered by underlying pathology.

Clinical and diagnostic findings

Ferritin levels increase by at least 25% during inflammatory states, driven primarily by pro-inflammatory cytokines like interleukin-1 (IL-1). This elevation occurs independently of actual iron stores.

• Disease associations: Hyperferritinemia is a non-specific but sensitive marker for chronic inflammation, acute infections, and autoimmune disorders such as systemic lupus erythematosus.
• Organ-specific and malignant triggers: Significant elevations are frequently observed in liver disease—where it reflects both inflammation and direct tissue injury—and in various malignancies (e.g., leukemia, neuroendocrine carcinomas) due to dysregulated iron metabolism.
• Anemia of Inflammation (AI): A classic diagnostic pattern in AI consists of elevated serum ferritin (>100 μg/L) paired with low transferrin saturation (TSAT <20%). This profile is essential for differentiating AI from absolute iron deficiency anemia, where both markers would be low.

Mechanistic explanations

The paradoxical finding of high ferritin and low circulating iron in inflammatory states is governed by the hepcidin-ferroportin axis.

• Hepcidin induction: Inflammatory cytokines, particularly interleukin-6 (IL-6), stimulate the liver to produce hepcidin.
• Iron sequestration: Hepcidin binds to ferroportin—the only known cellular iron exporter—on the surface of macrophages and enterocytes, causing its degradation.
• Reticuloendothelial trapping: This mechanism traps iron within the reticuloendothelial system (macrophages). While total body iron is abundant (reflected by high ferritin), it is functionally unavailable for erythropoiesis, leading to low serum iron and low transferrin saturation.

Clinical implications

For patients presenting with hyperferritinemia, clinicians must evaluate the broader clinical context to determine if the elevation is reactive.

• Differential diagnosis: Because ferritin is a robust acute-phase reactant, concurrent testing of C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) is often necessary to confirm an inflammatory state.
• Functional iron deficiency: The coexistence of high ferritin and low TSAT indicates "functional iron deficiency," where iron is present in the body but cannot be mobilized for red blood cell production.

Bottom line

The claim is fully supported. Ferritin is a sensitive acute-phase reactant that rises in response to infection, inflammation, liver disease, and malignancy. In anemia of inflammation, hepcidin-mediated sequestration leads to the characteristic laboratory finding of elevated ferritin alongside low transferrin saturation.